CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project establishes a network to develop patient-derived tumor organoids for cancer research, focusing on non-small cell lung cancer and B cell malignancies. It aims to create a realistic tumor microenvironment to test innovative therapies, including immunotherapy and radiotherapy.
We aim to establish a European network of experts in non-animal preclinical models to develop the next generation of patient-derived tumor organoids (PDTOs) for both solid and hematological cancers.
To this end, we have selected non-small cell lung cancer as a model, given its high incidence, and chronic lymphocytic leukemia and follicular lymphoma as representative B cell malignancies.These PDTOs will incorporate a novel, tissue-specific artificial extracellular matrix, created using tailored 3…
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Valencia
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Sittingbourne
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
